Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP337289.RAuF2DGn1tny51f048ccj3WOLJjWzWxr5MjkSKAnSsA3g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP337289.RAuF2DGn1tny51f048ccj3WOLJjWzWxr5MjkSKAnSsA3g130_assertion type Assertion NP337289.RAuF2DGn1tny51f048ccj3WOLJjWzWxr5MjkSKAnSsA3g130_head.
- NP337289.RAuF2DGn1tny51f048ccj3WOLJjWzWxr5MjkSKAnSsA3g130_assertion description "[MC1R Arg(160)/Arg(160) homozygotes were at increased risk (P = 0.027, odds ratio = 1.94) while TYR A2/A2 homozygotes were at reduced risk of prostate cancer (P = 0.033, odds ratio = 0.48).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP337289.RAuF2DGn1tny51f048ccj3WOLJjWzWxr5MjkSKAnSsA3g130_provenance.
- NP337289.RAuF2DGn1tny51f048ccj3WOLJjWzWxr5MjkSKAnSsA3g130_assertion evidence source_evidence_literature NP337289.RAuF2DGn1tny51f048ccj3WOLJjWzWxr5MjkSKAnSsA3g130_provenance.
- NP337289.RAuF2DGn1tny51f048ccj3WOLJjWzWxr5MjkSKAnSsA3g130_assertion SIO_000772 11720436 NP337289.RAuF2DGn1tny51f048ccj3WOLJjWzWxr5MjkSKAnSsA3g130_provenance.
- NP337289.RAuF2DGn1tny51f048ccj3WOLJjWzWxr5MjkSKAnSsA3g130_assertion wasDerivedFrom befree-2016 NP337289.RAuF2DGn1tny51f048ccj3WOLJjWzWxr5MjkSKAnSsA3g130_provenance.
- NP337289.RAuF2DGn1tny51f048ccj3WOLJjWzWxr5MjkSKAnSsA3g130_assertion wasGeneratedBy ECO_0000203 NP337289.RAuF2DGn1tny51f048ccj3WOLJjWzWxr5MjkSKAnSsA3g130_provenance.